ATE241981T1 - Verwendung von 4-aminopyridin zur behandlung von schmerz und spastik folgende einer verletzung des rückenmarks - Google Patents

Verwendung von 4-aminopyridin zur behandlung von schmerz und spastik folgende einer verletzung des rückenmarks

Info

Publication number
ATE241981T1
ATE241981T1 AT94902578T AT94902578T ATE241981T1 AT E241981 T1 ATE241981 T1 AT E241981T1 AT 94902578 T AT94902578 T AT 94902578T AT 94902578 T AT94902578 T AT 94902578T AT E241981 T1 ATE241981 T1 AT E241981T1
Authority
AT
Austria
Prior art keywords
aminopyridine
spinal cord
spastic
resulting
cord injury
Prior art date
Application number
AT94902578T
Other languages
English (en)
Inventor
Robert R Hansebout
Andrew R Blight
Original Assignee
Canadian Spinal Res Org
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canadian Spinal Res Org filed Critical Canadian Spinal Res Org
Application granted granted Critical
Publication of ATE241981T1 publication Critical patent/ATE241981T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
AT94902578T 1992-12-18 1993-12-20 Verwendung von 4-aminopyridin zur behandlung von schmerz und spastik folgende einer verletzung des rückenmarks ATE241981T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002085785A CA2085785C (en) 1992-12-18 1992-12-18 The use of 4-aminopyridine in the treatment of a neurological condition
PCT/CA1993/000554 WO1994014439A1 (en) 1992-12-18 1993-12-20 The use of 4-aminopyridine in the treatment of a neurological condition

Publications (1)

Publication Number Publication Date
ATE241981T1 true ATE241981T1 (de) 2003-06-15

Family

ID=4150879

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94902578T ATE241981T1 (de) 1992-12-18 1993-12-20 Verwendung von 4-aminopyridin zur behandlung von schmerz und spastik folgende einer verletzung des rückenmarks

Country Status (19)

Country Link
US (1) US5545648A (de)
EP (1) EP0626848B1 (de)
JP (1) JP3474569B2 (de)
KR (1) KR100301415B1 (de)
AT (1) ATE241981T1 (de)
AU (1) AU676251B2 (de)
BG (1) BG62272B1 (de)
BR (1) BR9305909A (de)
CA (1) CA2085785C (de)
CZ (1) CZ284441B6 (de)
DE (1) DE69333014T2 (de)
ES (1) ES2199957T3 (de)
FI (1) FI943765A7 (de)
HU (1) HU219583B (de)
NO (2) NO308644B1 (de)
NZ (1) NZ258844A (de)
RU (1) RU2160590C2 (de)
SK (1) SK280922B6 (de)
WO (1) WO1994014439A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792743A (en) * 1995-04-19 1998-08-11 Acorda Therapeutics Method for promoting neural growth comprising administering a soluble neural cell adhesion molecule
JPH09315972A (ja) * 1996-03-22 1997-12-09 Chugai Pharmaceut Co Ltd 脊髄損傷治療剤
AU8619698A (en) 1997-07-25 1999-02-16 Ban C. H. Tsui Devices, systems and methods for determining proper placement of epidural catheters
US7582680B1 (en) 1998-11-12 2009-09-01 Purdue Research Foundation Methods and compositions for treating mammalian spinal cord injuries
WO2000047210A1 (en) * 1999-02-09 2000-08-17 Uab Research Foundation Use of 4-amino pyridine for treatment of peripheral neuropathies
NO324322B1 (no) 2001-02-26 2007-09-24 Dynea Oy Anvendelse av herder samt fremgangsmate ved liming
EP1389121B1 (de) * 2001-04-24 2012-02-22 Purdue Research Foundation Verfahren und zusammensetzungen zur behandlung von nervengewebeverletzungen in säugetieren
US20040047843A1 (en) * 2002-02-12 2004-03-11 Uab Research Foundation Method for spinal cord reconnection
US8729107B2 (en) * 2002-12-06 2014-05-20 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
AU2003298034B2 (en) * 2002-12-06 2011-04-21 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
JP4533590B2 (ja) * 2003-02-28 2010-09-01 ファイザー株式会社 脊髄損傷患者における疼痛又は痙性軽減用医薬組成物
US20050192321A1 (en) * 2003-09-15 2005-09-01 Meythaler Jay M. Treatment of neuropathy with rapid release aminopyridine
US8007826B2 (en) * 2003-12-11 2011-08-30 Acorda Therapeutics, Inc. Sustained release aminopyridine composition
US8354437B2 (en) 2004-04-09 2013-01-15 Acorda Therapeutics, Inc. Method of using sustained release aminopyridine compositions
JP2014503596A (ja) * 2011-01-28 2014-02-13 アコーダ セラピューティクス，インコーポレーテッド 脳性麻痺を治療するためのカリウムチャネル遮断薬の使用
US8924325B1 (en) * 2011-02-08 2014-12-30 Lockheed Martin Corporation Computerized target hostility determination and countermeasure
TWI592156B (zh) * 2011-10-04 2017-07-21 艾可達醫療公司 使用胺基吡啶以治療與中風有關之感覺動作損傷之方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508715A (en) * 1981-07-01 1985-04-02 University Of Georgia Research Foundation, Inc. Antagonism of central nervous system drugs by the administration of 4-aminopyridine alone or in combination with other drugs
EP0408650A1 (de) * 1988-04-08 1991-01-23 Massachusetts Institute Of Technology Verfahren und zusammensetzung für die behandlung neurologischer störungen
IE82916B1 (en) * 1990-11-02 2003-06-11 Elan Corp Plc Formulations and their use in the treatment of neurological diseases

Also Published As

Publication number Publication date
KR100301415B1 (ko) 2001-11-22
SK96994A3 (en) 1995-04-12
CA2085785A1 (en) 1994-06-19
BR9305909A (pt) 1997-10-21
KR950700062A (ko) 1995-01-16
WO1994014439A1 (en) 1994-07-07
FI943765A0 (fi) 1994-08-16
FI943765L (fi) 1994-10-14
BG99047A (bg) 1995-06-30
FI943765A7 (fi) 1994-10-14
HUT68171A (en) 1995-05-29
HU9402647D0 (en) 1994-11-28
EP0626848B1 (de) 2003-06-04
NO308644B1 (no) 2000-10-09
JP3474569B2 (ja) 2003-12-08
CA2085785C (en) 2005-03-15
CZ225494A3 (en) 1995-03-15
JPH08504772A (ja) 1996-05-21
CZ284441B6 (cs) 1998-11-11
NO2012003I1 (no) 2012-02-13
AU5691194A (en) 1994-07-19
DE69333014D1 (de) 2003-07-10
RU2160590C2 (ru) 2000-12-20
BG62272B1 (bg) 1999-07-30
AU676251B2 (en) 1997-03-06
SK280922B6 (sk) 2000-09-12
EP0626848A1 (de) 1994-12-07
US5545648A (en) 1996-08-13
NZ258844A (en) 1997-04-24
NO2012003I2 (no) 2013-02-18
NO943049D0 (no) 1994-08-17
NO943049L (no) 1994-10-17
HU219583B (hu) 2001-05-28
RU94041207A (ru) 1996-06-20
DE69333014T2 (de) 2004-05-06
ES2199957T3 (es) 2004-03-01

Similar Documents

Publication Publication Date Title
NO2012003I2 (no) 4-aminopyridin
ATE164067T1 (de) Verwendung von riluzole zur behandlung von traumatischen neurologischen-schädigungen
NO961478L (no) Levobupivacaine anvendelig for kontroll av kronisk smerte
ATE207351T1 (de) Verwendung vonmodafinil zur behandlung von atemstillstand im schlaf und zentral erregten atembeschwerden
ATE198830T1 (de) Verwendung von nikotinanalogen zur behandlung von degenerativen erkrankungen des nervensystems
ATE196847T1 (de) Verwendung von mannosephosphaten zur behandlung von fibrotischen störungen
DE59409312D1 (de) Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten
ATE218873T1 (de) Verwendung von wasser mit verringertem deuterium- gehalt zur herstellung von hygienischen und kosmetischen präparaten
DE69526937D1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
DE69328193D1 (de) Verwendung von prodelphidinen zur behandlung von arthrose
TW261532B (de)
DE69516110D1 (de) Verwendung von riluzol zur behandlung mitochondrialer erkrankungen
DE50103012D1 (de) Verwendung von hyaluronidase zur prophylaxe und behandlung von herz-kreislauf-erkrankungen
DE69510933D1 (de) Amidderivate und ihre therapeutische anwendung
DE69525631D1 (de) Verwendung von prostaglandinen zur herstellung eines arzneimittels zur prävention und behandlung des sekundären katarakts
DE69227899D1 (de) Verwendung eines benzimidazolwurmmittels zur behandlung von mikrosporeninfektionen
DE59409813D1 (de) Imidazolochinoxalinone zur behandlung zentralnervöser erkrankungen
ATE150645T1 (de) Verwendung von bmy 14802 zur behandlung von angstzuständen bei patienten mit benzodiazepin- entzugserscheinungen
ATE195422T1 (de) Verwendung von piperazinderivaten zur behandlung von kognitiven erkrankungen
ATE177637T1 (de) Triazolochinazoline zur behandlung zentralnervöser erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties